For Prescribers, Founders, Executives, and Organisations Building
The Future of Cannabinoid Enterprise
.
But most organisations still struggle to use any of them.
.
The challenge is no longer access to science.
The challenge is translation — turning research into decisions, decisions into capability, and capability into competitive advantage.
That gap costs organisations time, money, and opportunity. Every day without a scientific foundation is a day of avoidable exposure.
Hi, I'm Christopher Tasker — CEO & Founder, Global Cannabinoid Solutions
I hold an MRes in Cannabinoid Research from the University of Nottingham, serve as Scientific Adviser to the Cannabis Trades Association, and am a Trustee of an intractable epilepsy charity.
I began in the laboratory. Conducting original research into the endocannabinoid system in human cancer tissue.
The last five years have been spent translating that science into the world's first online cannabinoid science lab — accessible to any organisation, anywhere in the world.
GCS is a living research lab, expert network, and strategic capability engine built to serve the organisations making the decisions that matter.
~10 years of cannabinoid research and industry development
1,000+ ecosystem members and growing
50+ experts across multiple disciplines and markets
International clinical and commercial reach
A living scientific intelligence environment — where the knowledge is structured, the AI never sleeps, the experts are real, and the community is already building the future of this industry.
Before you explore — hear directly from Christopher on what GCS is, why it exists, and how it can help you."
Ready to explore what's inside?
Fusion is our signature process designed to help organisations align teams, unlock innovation, strengthen decision-making, and build long-term capability through Scientific Cannabis Intelligence.
Build a scientifically capable organisation.
Deploy scientific infrastructure into your business.
Turn scientific intelligence into competitive advantage.
Through our Fusion process, we help organisations transform fragmented cannabinoid science into operational clarity, aligned teams, stronger decision-making, and scalable scientific capability.
A Co-Lab is a uniquely tailored private scientific intelligence environment — built inside the GCS ecosystem and deployed simultaneously across every level of the business.
Without hiring a single scientist, building an internal team, or waiting years for results — deployed digitally, powered by 100 years of cannabinoid research, available to every layer of your organisation from day one.
Find out If a Co-LAB is right for you
The GCS Lab eliminates the hidden costs that slow progress in cannabis:
Long R&D timelines
Fragmented expert advice
Inconsistent scientific understanding
Decisions made without shared foundations
By translating global cannabinoid science into a living, governed environment, the Lab allows organisations to:
Establish literacy before execution
Build capability without guesswork
Reduce clinical, regulatory, and reputational risk
Condense timelines from years to months
When:
• Making high-stakes strategic or investment decisions
• Entering new markets or jurisdictions
• Approving products, partnerships, or acquisitions
• Governing risk in a rapidly evolving sector
How The Lab Is Used:
• Gain a systems-level view of the cannabis ecosystem
• Understand what researchers see — not just summaries
• Compress years of learning into decision-ready intelligence
• Prepare for board-level decisions with scientific confidence
Outcome:
• Better capital allocation
• Fewer strategic blind spots
• Clearer long-term vision
• Independence from fragmented advisors
When:
• Assessing cannabis investments or partnerships
• Validating claims made by founders or operators
• Avoiding exposure to regulatory or scientific risk
• Identifying future-facing opportunities early
How The Lab Is Used:
• Conduct science-led due diligence
• Understand biological and regulatory constraints
• Evaluate innovation claims against real research
• Build conviction before capital is committed
Outcome:
• Protected capital
• Higher-quality deal flow
• Reduced downside risk
• Stronger long-term returns
When:
• Introducing cannabinoid medicines into practice
• Scaling a clinic or onboarding new clinicians
• Responding to regulatory scrutiny or inspection
• Managing complex patients and prescribing variability
How The Lab Is Used:
• Establish ECS and cannabinoid literacy across teams
• Embed science-led prescribing and safeguarding frameworks
• Standardise clinical language, risk assessment, and governance
• Provide on-demand scientific clarification when cases escalate
Outcome:
• Safer prescribing
• Stronger governance
• Reduced clinical risk
• Improved patient outcomes and continuity of care
When:
• Dispensing CBPMs under evolving regulatory expectations
• Managing third-party prescribers
• Handling safeguarding, audits, or governance gaps
• Scaling CBPM operations responsibly
How The Lab Is Used:
• Build cannabinoid-specific governance literacy
• Align teams around evidence-led safety frameworks
• Reduce errors caused by miscommunication or uncertainty
• Prepare for regulatory inspection with defensible systems
Outcome:
• Reduced compliance risk
• Stronger audit readiness
• Clearer clinical oversight
• Safer patient pathways
When:
• Developing new cannabinoid products or formulations
• Evaluating emerging technologies or synthetic pathways
• Stress-testing innovation claims before market entry
• Avoiding costly R&D dead-ends
How The Lab Is Used:
• Interrogate the real science behind innovation opportunities
• Identify where intellectual property is actually created
• Separate hype from defensible research
• Replace years of fragmented R&D with structured intelligence
Outcome:
• Faster innovation cycles
• Reduced R&D waste
• Stronger IP positioning
• Higher probability of commercial success
When:
• Developing guidance, frameworks, or policy positions
• Supporting sector-wide education and standards
• Engaging with regulators or government bodies
• Ensuring public safety and trust
How The Lab Is Used:
• Build ECS and cannabinoid literacy at scale
• Translate science into defensible policy insight
• Support responsible sector development
• Reduce misinformation-driven harm
Outcome:
• Better policy decisions
• Increased public trust
• Stronger sector credibility
• Long-term system resilience
Every journey through the GCS ecosystem begins with one step. Here are the most common first moves.
The £495 is a deposit — applied in full against your Co-LAB investment. It covers a full Scientific Readiness Audit with Christopher, a written intelligence report with commercial cost quantification, and a Co-LAB design call that maps exactly what your organisation needs and how to build it.
Deposit applied to your Co-LAB investment
Your team is patient-facing. The science is moving fast. The gap is a liability.
GreenShield Pro is a CPD-aligned cannabis science literacy certification completable in 90 minutes. Four modules, a final assessment, and a certificate your team can use for revalidation evidence.
Intelligence compounds. Ignorance costs.
The Executive Cannabis Intelligence System compresses 10,000 hours of fragmented scientific exposure into under 12 hours of structured, on-demand content — across 21 lessons and four levels. The DIY equivalent costs £125,000 and years of your life.
For everyone · Free · Instant results
Take the Lab Test and find out exactly where you stand — scientifically, clinically, and commercially. 15 minutes. A scored diagnostic across five capability dimensions. An AI-generated intelligence report built from your answers.
Most people say it's the most useful 5 minutes they've spent in this industry. And it costs nothing.
Your Vision, Powered By The Full Force of Cannabinoid Science
Whether you're exploring cannabinoid science for the first time or building the next generation of cannabinoid healthcare, products, research, or innovation, GCS helps ambitious people and organisations move forward with confidence.